Σellas Clinicals is a dedicated clinical trial and research facility and it functions as a site management organization (SMO). Our focus is the conduct of clinical trials (Phases I-IV) sponsored by CROs, pharmaceutical and biotechnology companies. Our mission is to provide access to cutting-edge care through innovative treatment and research protocols to patients with acute and chronic diseases.
We have established affiliations with academic and research centers worldwide. We have a highly qualified group of US & Europe trained and board-certified physicians and specialized staff, including study nurses, clinical trial coordinators, project managers, regulatory affairs specialists and pharmacists, all of whom are trained according to ICH-GCP guidelines. Σellas Clinicals is responsible for facilitating patient recruitment and coordinating the execution of the trial, assuring timely and efficient data collection, CRF completion and quality control testing. The spectrum of diseases in which we can administer protocols is very broad and encompasses all medical specialties. In particular we are most involved with studies in cardiology, neurology, rheumatology and hematology/oncology.
Our Clinical Research facility provides the following advantages:
• our medical staff, physician network and non-medical support team have broad experience in clinical research
• we have established a reputation for conducting high-quality research
• we assure faster clinical trial completion by meeting or exceeding patient enrollment targets
• we have a far outreach in Europe and mid-East
We currently have underway over ten clinical protocols in the fields of cardiology, virology, hematology, rheumatology, neurology and osteoporosis.
Our patients’ well-being is our top priority. Our sophisticated patient management and triage system allows us to assess each treatment protocol that a patient may be a candidate for.
Accelerated Patient Enrollment
Σellas uses a proprietary software that allows us to strategize patient enrollment across all medical indications and, as such, target a particular treatment option individually to the patient in need. We have a database of more than 50,000 patients due to our affiliations in order to run ad-hoc and meta-analyses to further optimize patient treatments.
We have conducted numerous clinical trials and treatment protocols in a wide range of medical indications. Our comprehensive experience allows us to pursue a wide range of trials and treat patients in need.
Our goal is to provide patients who are seeking treatment in critical diseases access to the most innovative treatment and research options.
Σellas will provide access to tomorrow’s treatments today, in advance of health authority approvals, through clinical trials and telemedicine in a nurturing atmosphere that maximizes outcome.
We are here to serve, support, help and treat you!